5 things to know about Baxalta after Shire’s $30.6 billion bid By: MarketWatch August 05, 2015 at 16:04 PM EDT Baxalta makes drugs to treat rare diseases, like hemophilia, the blood disorder suffered by Russian Tsar Nicholas II’s son Alexei. Read More >> Related Stocks: Baxter International Macy's